Meet the One Million Strong – Ed M. from Ohio

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET ED Ed Murphy, CaregiverMilford, Ohio ED’S STORY My wife, Arlene, was diagnosed with colon cancer in September, 2004 while trying to find the source of her recently diagnosed anemia. During the surgery to remove the…  Read More

Meet the One Million Strong – Deborah Anders from Texas

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET DEBORAH Deborah Anders, Survivor From Austin, TX DEBORAH’S STORY I am a stage IV colorectal cancer survivor going on 6 years this May. I have been through fours kinds of chemotherapy and  seven surgeries.  I…  Read More

Meet the One Million Strong – Gordon C. from North Carolina

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET GORDON Gordon Cole, Survivor Greensboro, NC GORDON’S STORY Following his diagnosis of stage IV colorectal cancer in August 2003, Gordon has received radiation treatment, almost constant chemotherapy, a colon resection, two liver resections, RFA, a…  Read More

Stage II Colon Cancer – Chemo or No Chemo?

A brief in a running series from 2013 ASCO® conference: Prognostic Tests – to use or not use . . .  or rather  … To treat or not to treat? New studies for stage II colon cancer patients contemplating chemotherapy . by: Nancy Roach One of the toughest decisions for patients with stage II colon cancer is…  Read More

Experts Issue Practice-Changing Advice: Stop giving calcium/magnesium for oxaliplatin-caused neuropathy

For patients getting the common FOLFOX chemotherapy for colorectal cancer, many oncologists add intravenous calcium and magnesium, hoping to decrease the neuropathy (nerve damage) associated with oxaliplatin-based drugs. But this week, experts at the 2013 ASCO meeting (American Society of Clinical Oncology), announced strong evidence that the calcium/magnesium does no good in either preventing or decreasing…  Read More

FDA Approves Regorafenib for Metastatic CRC

  The FDA today approved the use of the drug regorafenib (brand name Stivarga) for patients whose metastatic colorectal cancer has progressed despite all currently approved treatment regimens. This is the second new drug approved by the FDA recently after a drought of 5 years in approving new treatments for metastatic colorectal cancer (mCRC). Regorafenib was placed…  Read More